The diagnostic value of anti-neutrophil cytoplasmic antibody testing in a routine clinical setting.

The diagnostic value of anti-neutrophil cytoplasmic antibody testing in a routine clinical setting.

Anti-neutrophil cytoplasmic antibody (ANCA) tests are a routine clinical assay in most UK hospitals. We examined the role of routine ANCA testing in achieving a diagnosis of systemic vasculitis in a routine clinical setting. From April 1996 to March 2000, 2734 samples from five hospital departments...

Full description

Bibliographic Details
Main Authors:	McLaren, J, Stimson, R, McRorie, E, Coia, J, Luqmani, R
Format:	Journal article
Language:	English
Published:	2001

Similar Items

Positive predictive value of anti-neutrophil cytoplasmic antibody (ANCA) testing for ANCA-associated systemic vasculitis (AASV) in a routine clinical setting
by: McLaren, J, et al.
Published: (2001)

A four year analysis of variation in use of the anti-neutrophil cytoplasmic antibody (ANCA) test as a screening tool for ANCA-associated systemic vasculitis (AAV) in a teaching hospital.
by: McLaren, J, et al.
Published: (2000)

Diagnosis and assessment of systemic vasculitis.
by: McLaren, J, et al.
Published: (2002)

Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis.
by: Basu, N, et al.
Published: (2014)

Patient perceptions of glucocorticoids in anti-neutrophil cytoplasmic antibody-associated vasculitis
by: Robson, J, et al.
Published: (2017)

Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis.
by: Guerry, M, et al.
Published: (2012)

Global ethnic and geographic differences in the clinical presentations of anti-neutrophil cytoplasm antibody-associated vasculitis
by: Pearce, F, et al.
Published: (2017)

A disease-specific patient-reported outcome for anti-neutrophil cytoplasmic antibody–associated vasculitis: scale structure and measurement properties of the anti-neutrophil cytoplasmic antibody-associated vasculitis patient-reported outcome measure
by: Robson, J, et al.
Published: (2017)

Eosinophils in anti-neutrophil cytoplasmic antibody associated vasculitis
by: Thomas Hellmark, et al.
Published: (2019-03-01)

Rituximab in combination with corticosteroids for the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis: a NICE single technology appraisal.
by: Latimer, N, et al.
Published: (2014)

Rituximab in Combination with Corticosteroids for the Treatment of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A NICE Single Technology Appraisal
by: Latimer, N, et al.
Published: (2014)

DEVELOPMENT OF DIAGNOSTIC CRITERIA FOR PRIMARY ANCA-ASSOCIATED SYSTEMIC VASCULITIS (AASV)
by: McLaren, J, et al.
Published: (2003)

Advances in the Assessment and Treatment of Anti-Neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis
by: Ni A, et al.
Published: (2024-12-01)

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in Kidney Transplantation
by: Valentina Binda, et al.
Published: (2021-12-01)

Relapse in Anti-Neutrophil Cytoplasm Antibody (ANCA)–Associated Vasculitis
by: Alan D. Salama
Published: (2020-01-01)

Scale Structure and Measurement Properties of a Disease Specific Patient-Reported Outcome for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
by: Robson, J, et al.
Published: (2016)

Cytoplasmic-anti-neutrophil cytoplasmic antibodies targeting myeloperoxidase in Wegener′s granulomatosis: A rare phenomenon
by: Bhavana M Venkatesh, et al.
Published: (2014-01-01)

DIAGNOSTIC CRITERIA FOR ANCA-ASSOCIATED PRIMARY SYSTEMIC VASCULITIS (AASV) IN PATIENTS PRESENTING WITH ACUTE PULMONARY AND/OR RENAL DISEASE
by: McLaren, J, et al.
Published: (2004)

Cardiovascular and Cerebrovascular Outcomes in Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis
by: Shiyu Xiao, et al.
Published: (2024-01-01)

Clonal hematopoiesis in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis
by: Christopher Maximilian Arends, et al.
Published: (2020-06-01)

Role of complement activation in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis
by: Tadasu Kojima, et al.
Published: (2022-12-01)

Anti-neutrophil cytoplasmic antibodies in new-onset systemic lupus erythematosus
by: Fang Su, et al.
Published: (2017-08-01)

Anti-neutrophil cytoplasmic antibody associated vasculitis in patients with rheumatoid arthritis
by: Haiting Wu, et al.
Published: (2022-04-01)

A glance into the future of anti-neutrophil cytoplasmic antibody-associated vasculitis
by: Marta Casal Moura, et al.
Published: (2022-11-01)

Clinical features of anti-neutrophil cytoplasmic antibody-associated systemic vasculitis in French children
by: Salomon R, et al.
Published: (2011-09-01)

Clinical significance of HEp-2 cell cytoplasmic patterns in anti-neutrophil cytoplasmic antibody associated vasculitis
by: Naidan Zhang, MS, et al.
Published: (2022-06-01)

Rheumatoid constrictive pericarditis
by: McRorie, E, et al.
Published: (1997)

Rheumatoid constrictive pericarditis.
by: McRorie, E, et al.
Published: (1997)

Rheumatoid constrictive pericarditis.
by: McRorie, E, et al.
Published: (1997)

Oral Microbiota Profile in Patients with Anti-Neutrophil Cytoplasmic Antibody–Associated Vasculitis
by: Anders Esberg, et al.
Published: (2022-08-01)

Cardiovascular Outcomes Are Worse In Microscopic Polyangiitis Compared To Granulomatosis With Polyangiitis: Data From An Inception Cohort Of Patients With Anti-Neutrophil Cytoplasm Antibody Associated Systemic Vasculitis
by: Mistry, A, et al.
Published: (2013)

Anti-neutrophil extracellular trap antibody in a patient with relapse of anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report
by: Haruki Shida, et al.
Published: (2018-06-01)

Glucocorticoid Minimization in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: An International Survey of Clinicians
by: David Massicotte-Azarniouch, et al.
Published: (2024-08-01)

Anti-myeloperoxidase IgM B cells in anti-neutrophil cytoplasmic antibody-associated vasculitis
by: CM Wortel, et al.
Published: (2025-02-01)

Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis Study Group trials.
by: Robson, J, et al.
Published: (2014)

EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.
by: Hellmich, B, et al.
Published: (2007)

Immunofluorescence (IF) pattern, autoantigens of anti-neutrophil cytoplasmic antibodies (ANCA) and their clinical associations
by: Masita Arip,, et al.
Published: (2010)

Pulmonary manifestations associated with positive anti neutrophil cytoplasmic antibodies: The tip of the iceberg
by: Rania Kaddoussi, et al.
Published: (2024-01-01)

Clinical significance of myeloperoxidase-anti-neutrophil cytoplasmic antibody in idiopathic interstitial pneumonias.
by: Hironao Hozumi, et al.
Published: (2018-01-01)

Application of biological agents in the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis
by: Weijun Liu, et al.
Published: (2024-05-01)